首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >Interaction between insulin-like growth factor binding protein-related protein 1 and trans-forming growth factor beta 1 in primary hepatic stellate cells
【24h】

Interaction between insulin-like growth factor binding protein-related protein 1 and trans-forming growth factor beta 1 in primary hepatic stellate cells

机译:胰岛素样生长因子结合蛋白相关蛋白1与转化性生长因子β1在原代肝星状细胞中的相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We previously showed that insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) is a novel mediator in liver fibrosis. Transforming growth factor beta 1 (TGFβ1) is known as the strongest effector of liver fi-brosis. Therefore, we aimed to investigate the detailed interac-tion between IGFBPrP1 and TGFβ1 in primary hepatic stellate cells (HSCs). METHODS: We overexpressed TGFβ1 or IGFBPrP1 and in-hibited TGFβ1 expression in primary HSCs for 6, 12, 24, 48, 72, and 96 hours to investigate their interaction and observe the accompanying expressions of α-smooth muscle actin (α-SMA), collagen I, fibronectin, and phosphorylated-mothers against decapentaplegic homolog 2/3 (p-Smad2/3). RESULTS: We found that the adenovirus vector encoding the TGFβ1 gene (AdTGFβ1) induced IGFBPrP1 expression while that of α-SMA, collagen I, fibronectin, and TGFβ1 increased gradually. Concomitantly, AdIGFBPrP1 upregulated TGFβ1, α-SMA, collagen I, fibronectin, and p-Smad2/3 in a time-de-pendent manner while IGFBPrP1 expression was decreased at 96 hours. Inhibition of TGFβ1 expression reduced the IGFB-PrP1-stimulated expression of α-SMA, collagen I, fibronectin, and p-Smad2/3. CONCLUSIONS: These findings for the first time suggest the existence of a possible mutually regulation between IGFBPrP1 and TGFβ1, which likely accelerates liver fibrosis progression. Furthermore, IGFBPrP1 likely participates in liver fibrosis in a TGFβ1-depedent manner, and may act as an upstream regu-latory factor of TGFβ1 in the Smad pathway.
机译:背景:我们以前表明,胰岛素样生长因子结合蛋白相关蛋白1(IGFBPrP1)是肝纤维化的新型介体。转化生长因子β1(TGFβ1)被称为肝纤维化的最强效应子。因此,我们旨在研究原发性肝星状细胞(HSC)中IGFBPrP1和TGFβ1的详细相互作用。方法:我们在6、12、24、48、72和96小时内过度表达TGFβ1或IGFBPrP1并抑制TGFβ1表达,以研究它们的相互作用并观察α-平滑肌肌动蛋白(α-SMA)的伴随表达,胶原蛋白I,纤连蛋白和磷酸化母亲对抗去甲肾上腺皮质激素同系物2/3(p-Smad2 / 3)。结果:我们发现编码TGFβ1基因的腺病毒载体(AdTGFβ1)诱导了IGFBPrP1的表达,而α-SMA,胶原I,纤连蛋白和TGFβ1的表达逐渐增加。同时,AdIGFBPrP1以时效方式上调TGFβ1,α-SMA,胶原蛋白I,纤连蛋白和p-Smad2 / 3,而IGFBPrP1的表达在96小时时降低。抑制TGFβ1表达可降低IGFB-PrP1刺激的α-SMA,胶原I,纤连蛋白和p-Smad2 / 3的表达。结论:这些发现首次表明IGFBPrP1和TGFβ1之间可能存在相互调节,这可能加速肝纤维化进程。此外,IGFBPrP1可能以依赖TGFβ1的方式参与肝纤维化,并可能在Smad途径中充当TGFβ1的上游调节因子。

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2017年第004期|395-404|共10页
  • 作者单位

    Department of Gastroenterology and Hepatology, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Department of Gastroenterology and Hepatology, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Experimental Center of Science and Research, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Key Laboratory of Cell Physiology, Provincial Department of the Ministry of Education, Shanxi Medical University, Taiyuan 030001, China;

    Department of Gastroenterology and Hepatology, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Experimental Center of Science and Research, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Key Laboratory of Cell Physiology, Provincial Department of the Ministry of Education, Shanxi Medical University, Taiyuan 030001, China;

    Department of Gastroenterology and Hepatology, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Experimental Center of Science and Research, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Key Laboratory of Cell Physiology, Provincial Department of the Ministry of Education, Shanxi Medical University, Taiyuan 030001, China;

    Department of Gastroenterology and Hepatology, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Experimental Center of Science and Research, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Key Laboratory of Cell Physiology, Provincial Department of the Ministry of Education, Shanxi Medical University, Taiyuan 030001, China;

    Department of Gastroenterology and Hepatology, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Experimental Center of Science and Research, The First Clinical Hospital of Shanxi Medical University, Taiyuan 030001, China;

    Key Laboratory of Cell Physiology, Provincial Department of the Ministry of Education, Shanxi Medical University, Taiyuan 030001, China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号